Table 4.
Outcomes | PD | AP | VP | Control | PD | AP | VP | Control | PD | AP | VP | Control |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 monthly rate × 1,000 | 2020 monthly rate × 1,000 | 2020 vs. 2019 rate ratios (95% CI) | ||||||||||
Any urgent hospital admission | 13.4 | 23 | 17.3 | 10.7 | 17.6 | 33.5 | 9.3 | 11.6 | 1.3 (1–1.8) | 1.4 (0.70–3.1) | 0.54 (0.17–1.6) | 1.1 (0.98–1.2) |
Any disease-specific hospital admission | 8.8 | 16.9 | 23.1 | 9.2 | 18.4 | 22.9 | 10.9 | 9.9 | 2.1 (1.5–3.0) | 1.4 (0.56–3.3) | 0.47 (0.16–1.2) | 1.1 (0.96–1.2) |
Major injuries | 1.9 | - | 13 | 1.9 | 5.7 | 3.5 | 3.1 | 1.7 | 3.0 (1.5–6.2) | - | 0.24 (0.03–1.2) | 0.93 (0.72–1.2) |
Infections | 1.5 | 7.7 | 1.4 | 1.8 | 4.9 | 12.3 | 4.7 | 2.3 | 3.3 (1.5–7.2) | 1.6 (0.4–6.4) | 3.2 (0.3–169.5) | 1.3 (0.99–1.6) |
Gastro-intestinal events | 1.1 | 1.5 | 4.3 | 0.49 | 0.39 | - | - | 0.73 | 0.35 (0.07–1.7) | - | - | 1.5 (0.94-2.3) |
Psychiatric events | 2.3 | 7.7 | 4.3 | 1.4 | 3.1 | 1.8 | 3.1 | 1.2 | 1.4 (0.66–2.9) | 0.23 (0.05–2.1) | 0.72 (0.06–6.3) | 0.91 (0.67–1.2) |
Hypotension | 0.56 | - | - | 0.48 | 0.98 | 5.3 | - | 0.33 | 1.7 (0.41–7.3) | - | - | 0.69 (0.40–1.2) |
Thromboembolic events | - | - | - | 0.12 | 0.20 | - | - | 0.21 | - | - | - | 1.7 (0.69-4.0) |
Coronary artery disease | 0.56 | - | 1.4 | 0.56 | 0.59 | 1.8 | 1.6 | 0.51 | 1.0 (0.21–5.2) | - | 1.08 (0.01–84.5) | 0.91 (0.56–1.5) |
Heart failure | 0.56 | 1.5 | 1.4 | 1.5 | 1.8 | 1.8 | 6.2 | 1.8 | 3.1 (0.85–11.5) | 1.15 (0.01–30.1) | 4.3 (0.43–212) | 1.2 (0.90–1.6) |
Ischaemic stroke | 0.19 | - | - | 0.81 | 0.59 | - | - | 0.81 | 3.1 (0.32–30.0) | - | - | 1.0 (0.68–1.5) |
Haemorrhagic stroke | 0.19 | - | - | 0.22 | 0.20 | - | - | 0.27 | 1.0 (0.07–16.6) | - | - | 1.2 (0.61–2.5) |
The last three columns show rate ratios comparing 2020 monthly rates to 2019 monthly rates within each cohort. In bold statistically significant rate ratios.
PD, Parkinson's disease; AP, Atypical parkinsonism; VP, Vascular parkinsonism.